Dr. Kaylen Silverberg, an Ovation Fertility partner physician, uses preimplantation genetic testing, PGT, to better assess the likelihood that any given embryo will implant and grow into a healthy baby. “Looking at the genes, rather than judging from outward appearances, allows us to select the healthiest embryo for transfer to the uterus. While this doesn’t guarantee a live birth, it does increase the likelihood far beyond what we’ve had in the past. With this method, we can do a much better job of helping women achieve a pregnancy the first time with IVF. Whereas before we had national success rates of 30-40% per embryo transfer, now we are able to reach rates as high as 70-80% per embryo transfer.”

See Dr. Silverberg on Fox News—New York

Preimplantation genetic testing, PGT, is a new scientific methodology for selecting an embryo that has the highest probability of becoming a baby. This technology not only increases IVF live birth rates far beyond what is currently experienced by couples, it also reduces the risk of miscarriage and allows for the transfer of a single embryo – essentially eliminating multiple pregnancy. The potential to have a single IVF cycle brings the cost of IVF down significantly for patients, insurers and society, effectively mitigating the down stream costs associated with multiple pregnancy.